immunologic recovery was studied in ten patients with aplastic anemia and 23 patients with hematologic malignancy who received hla-identical marrow grafts and cyclosporine postgrafting as prophylaxis against graft-versus-host disease .
C0010592
cyclosporine
C0018133
graft-versus-host disease